Novel curcumin derivatives loaded chitosan nanoparticles as therapeutic agents for alzheimer’s disease

dc.contributor.authorFernando ,A.K.M
dc.contributor.authorDahanayake,J.N
dc.date.accessioned2026-10-26T02:35:57Z
dc.date.available2026-10-26T02:35:57Z
dc.date.issued2025-05
dc.descriptionAbstract No: 2025_341 Page No 79
dc.description.abstractAlzheimer’s disease is an irreversible neurodegenerative disorder defined by signs and symptoms that include β-amyloid plaques, tau neurofibrillary tangles, and synaptic dysfunction.
dc.identifier.issn1012-8999
dc.identifier.urihttps://dr.ichemc.ac.lk/handle/123456789/611
dc.language.isoen
dc.publisherInstitute Of Chemistry Ceylon
dc.relation.ispartofseries42; 2
dc.subjectAcetylcholinesterase
dc.subjectAlzheimer’s disease
dc.subjectchitosan nanoparticles
dc.subjectcurcumin derivatives
dc.subjectmolecular docking
dc.titleNovel curcumin derivatives loaded chitosan nanoparticles as therapeutic agents for alzheimer’s disease
dc.title.alternativeAn in-silico evaluation
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Novel curcumin derivatives loaded chitosan nanoparticles as therapeutic agents for alzheimer’s disease.pdf
Size:
448.52 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections